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In anaesthetized rabbits, α1-adrenoceptor stimulation increases the propensity of repolarization-prolonging drugs to induce torsade de pointes
ventricular tachycardia. However, it is not known whether the stimulation of intracardiac α1-adrenoceptors, or the increased ventricular stretch
caused by extracardiac α1-adrenoceptor-mediated peripheral vasoconstriction and increased resistance, are the sensitizing factors. Accordingly,
this study investigated whether a sustained load-induced left ventricular stretch or stimulation of the intracardiac α1-adrenoceptors with 100 nM
methoxamine, or the co-application of these two, can assist dofetilide (100 nM) to elicit torsade de pointes in isolated Langendorff-perfused, rabbit
hearts. In the stretched hearts, a constant high level of stretch was produced by a water-filled left ventricular balloon inflated to a volume of 1.4 ml,
whereby the systolic and end-diastolic pressures virtually did not exceed the physiological range (≤157±11 mm Hg and ≤9±2 mm Hg,
respectively; mean±S.E.M.). Perfusion with dofetilide prolonged the QT interval significantly and indifferently in all hearts. Neither this stretch
nor methoxamine nor the in combination affected the QT interval, the heart rate or the coronary flow. Interestingly, neither the stretch (‘dofetilide+
stretch’ group, n=8 hearts), nor methoxamine (‘dofetilide+methoxamine’ group, n=8 hearts), nor the in combination (‘dofetilide+stretch+
methoxamine’ group, n=8 hearts) elevated the incidence of torsade de pointes as compared with the ‘dofetilide alone’ group (n=9 hearts) (0%,
25%, 0%, versus 44%, respectively). In conclusion, neither a sustained load-induced stretch nor α1-adrenoceptor stimulation nor the in
combination assisted dofetilide to induce torsade de pointes in isolated rabbit hearts, suggesting the importance of extracardiac α1-adrenoceptor
stimulation in this phenomenon.
© 2006 Elsevier B.V. All rights reserved.Keywords: Ventricular stretch; α1-Adrenergic receptor; Repolarization prolongation; Torsade de pointes; Proarrhythmia; QT interval1. Introduction
Most of the Class III antiarrhythmic agents, such as
dofetilide, block the rapidly activating delayed rectifier K+
current (IKr), and therefore lengthen the repolarization phase of
the action potential of the cardiomyocytes, represented as a
prolongation of the QT interval in the surface electrocardiogram
(ECG) (Belardinelli et al., 2003). However, prolongation of the
repolarization and the QT interval is a risk factor for the⁎ Corresponding author. Tel.: +36 62 545 220; fax: +36 62 544 568.
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doi:10.1016/j.ejphar.2006.03.014development of malignant tachyarrhythmias such as torsade de
pointes (Belardinelli et al., 2003).
Several hypotheses have been proposed as concerns the
generation of torsade de pointes, but the exact mechanism of
this arrhythmia is still not clear. In the most widely accepted
theory, the intrinsic transmural dispersion of repolarization is
amplified by any effect that reduces net repolarizing currents
(e.g. drugs such as dofetilide, certain ion channel mutations, or
remodelling of the ventricular wall) by preferential prolongation
of the repolarization of the M cells, which sets the stage for
circus movement reentrant arrhythmias (Belardinelli et al.,
2003). Furthermore, the reduction in net repolarizing currents
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tion-induced ventricular extrasystoles, which can provide the
initiating beat that triggers reentrant tachyarrhythmias (Belardi-
nelli et al., 2003). Thus, the mechanism of torsade de pointes
initiation involves the early afterdepolarization-induced ectopic
beat, while the mechanism of the arrhythmia maintenance
involves the reentry.
The in vivo experimental model of the acquired long QT
syndrome developed by Carlsson et al. (1990) utilizes
anaesthetized rabbits. The ability of a test agent to evoke
torsade de pointes is evaluated during co-administration of a
‘priming’ substance, the selective α1-adrenoceptor agonist
methoxamine (Carlsson et al., 1990) or phenylephrine (Farkas
et al., 1998, 2002). Although this model has been widely used to
examine the proarrhythmic activity of novel antiarrhythmics
and other non-cardiac agents, the mechanism by which the
priming agent facilitates torsade de pointes in rabbits is
unknown. Although Carlsson et al. (1990) hypothesized that
direct stimulation of the cardiac α1-adrenoceptors is the
facilitating factor in their model, this hypothesis has as yet not
been proven. On the other hand, it may also be hypothesized
that reflex bradycardia and/or an increased ventricular stretch,
which develop as a consequence of α1-adrenoceptor-mediated
peripheral vasoconstriction and increased resistance, are the
critical sensitizing factors in the rabbit model of acquired long
QT syndrome developed by Carlsson et al. However, this latter
hypothesis has not yet been proven either.
Acute mechanical stretch induces complex changes in the
heart muscle. An acute stretch during diastole may induce
membrane depolarizations resembling delayed afterdepolariza-
tions, whereas an acute stretch during systole usually shortens
the action potential and the refractory period of the myocytes in
a heterogeneous manner; however, action potential prolonga-
tion and the induction of early afterdepolarizations have also
been reported (Janse et al., 2003). Hence, an acute stretch can be
arrhythmogenic by (i) inducing triggered arrhythmias, e.g.
extrasystoles, when stretch-induced early or delayed after-
depolarizations reach the threshold, or (ii) facilitating reentrant
arrhythmias by the heterogeneous shortening of the action
potential and refractory period of the cardiomyocytes.
Despite intensive examinations of the arrhythmia genesis in
the long QT syndrome, so far no data have been published on
the contribution of a ventricular stretch to the development of
torsade de pointes. Similarly, despite the frequent use of the
anaesthetized rabbit model of the acquired long QT syndrome
(Carlsson et al., 1990), hardly any experimental data have
been published on the role of α1-adrenoceptor stimulation in
the model. Since a ventricular stretch, α1-adrenoceptor
stimulation and bradycardia can be separated from each
other in isolated Langendorff-perfused rabbit hearts, this
model is suitable for examining the effects of these factors
separately and in combination on the genesis of torsade de
pointes. Accordingly, the present study investigated whether
triggered arrhythmias induced by a constant high level of left
ventricular stretch are able to initiate torsade de pointes in the
presence of functional reentries caused by the repolarization-
lengthening dofetilide in the presence or the absence of α1-adrenoceptor stimulation in isolated Langendorff-perfused
rabbit hearts.
2. Methods
2.1. Animals and general methods
Female New Zealand white rabbits weighing 2.3–2.9 kg
were used for the experiments, as female gender may increase
the susceptibility to the generation of drug-induced torsade de
pointes in rabbits, similarly as in humans (Liu et al., 1999; Lu et
al., 2001). The animals were handled in accordance with the
European Community guidelines for the use of experimental
animals, and the protocol was reviewed and approved by the
Ethical Committee for the Protection of Animals in Research at
the University of Szeged, Hungary.
The animals were anticoagulated with sodium heparin (1000
international units) injected into the marginal ear vein and
stunned by a blow to the neck. The heart was rapidly removed
via thoracotomy and rinsed in ice-cold modified Krebs–
Henseleit buffer solution containing (in mM): NaCl 118.5,
CaCl2 2.5, glucose 11.1, MgSO4 0.5, NaH2PO4 1.2, NaHCO3
25, and KCl 3. The K+ concentration of 3 mM was chosen for
the buffer, as the proarrhythmic action of dofetilide tended to be
exacerbated by perfusion with 3 mM K+ versus 4 mM K+ in
isolated rabbit hearts (Barrett et al., 2001). The aorta was
cannulated and hung on a Langendorff apparatus. The hearts
were retrogradely perfused at a constant temperature of 37 °C
with the modified Krebs–Henseleit buffer solution described
above. A mixture of 95% O2 and 5% CO2 was bubbled through
the buffer, which was equilibrated to pH 7.4. All solutions were
filtered (10 μm pore size filter) before use. The perfusion
pressure was maintained constant at 70 mm Hg. Volume-
conducted ECG and left ventricular pressure (described later)
were recorded by using National Instruments data acquisition
hardware (PC card, National Instruments, Austin, TX, USA)
and SPEL Advanced Haemosys software (version 2.45,
Experimetria Ltd. and Logirex Software Laboratory, Budapest,
Hungary). Coronary flow was measured with a glass flowmeter
(Cole-Parmer Instrument Company, Vernon Hills, Illinois,
USA) positioned immediately above the retrogradely perfused
aorta.
2.2. Experimental protocol
In the first set of experiments, to find the appropriate
dofetilide concentration in terms of the proarrhythmic potential,
three groups of hearts [dofetilide 50 nM (n=8), dofetilide
100 nM (n=9), and control (solvent of dofetilide, n=10)] were
compared. In each heart, the drug perfusion was started after
15 min of initial perfusion with modified Krebs–Henseleit
solution, and lasted for 40 min. The choice of drug solution was
made by reference to a randomization table. Randomization was
achieved by coding each group with a letter whose meaning was
unknown to the operator. Blinded analysis was achieved by
using stock solutions prepared by a second operator, who did
not participate in the heart perfusion or data analysis.
Table 1
Incidence of arrhythmias
n Incidence of arrhythmias (%)
VPB BG Salvo Block VT TdP
Control 10 70 10 0 10 0 0
50 nM dofetilide 8 50 0 25 25 0 0
100 nM dofetilide 9 89 56 56 89 a 44 44
Dof+stretch 8 100 63 88 a 63 63 a 0
Dof+Methox 8 75 25 38 75 25 25
Dof+Methox+stretch 8 100 38 75 a 38 63 a 0
Values are percentage incidences of arrhythmias. Dof, 100 nM dofetilide;
Methox, 100 nM methoxamine; VPB, ventricular premature beat; BG,
bigeminy; Block, conduction block of any kind; VT, ventricular tachycardia
different from torsade de pointes; TdP, torsade de pointes ventricular
tachycardia. Group size is indicated by n.
a P<0.05 as compared with the Control group.
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group (Table 1) and it did so with an incidence which offered
scope for the examination of additional effects that can further
increase the incidence of this arrhythmia. This concentration
was therefore chosen and used in the remainder of the study.
In the second set of experiments, three groups of hearts (n=8
hearts in each group) were perfused with 100 nM dofetilide for
40 min after 15 min of initial perfusion with modified Krebs–
Henseleit solution. In two of the three dofetilide-perfused
groups of hearts, methoxamine at a concentration of 100 nM
was added to the dofetilide-containing perfusion solution. This
concentration of methoxamine was chosen since 10 μM and
1 μM methoxamine reduced the coronary flow in rabbit hearts
by more than 50%, while 100 nM methoxamine did not alter the
coronary flow appreciably in our pilot studies (data not shown).
In each heart, a non-elastic balloon was inserted into the left
ventricle via the mitral valve and was connected to a pressure
transducer. The intraventricular balloon was filled with water at
a constant volume of 1.4 ml throughout the whole experiment in
the group of hearts perfused only with dofetilide and the vehicle
of methoxamine (‘dofetilide+stretch’ group) and in one of the
groups of hearts perfused with dofetilide and methoxamine
(‘dofetilide+methoxamine+stretch’ group). This balloon vol-
ume was chosen since in preliminary studies it provided the
approximate maximum left ventricular developed pressure
(developed pressure=systolic pressure−end-diastolic pressure)
without damaging the hearts (data not shown). The balloon was
not inflated in the other group of hearts perfused with dofetilide
and methoxamine (‘dofetilide+methoxamine’ group). The
second set of experiments was randomized, too.
Individual measurements of coronary flow, left ventricle
pressure and ECG variables were made every 5 min and 1 min
before and 1 min after the introduction of drug perfusion. At the
end of each experiment, the atria were removed from the heart
and the ventricles were weighed.
2.3. Drugs and materials
Perfusion solutions were prepared fresh each day. In the first
set of experiments, the ‘vehicle stock’ was a 2 ml solution
containing 1.8 ml of plain water+0.2 ml of 1 M NaOH. Thecontrol solution contained 0.12 ml of this ‘vehicle stock’ in 3 l
of modified Krebs–Henseleit solution. The 100 nM dofetilide
solution was prepared from 2 ml of ‘dofetilide stock’ (consisting
of 2.21 mg of dofetilide dissolved in 1.8 ml of water+0.2 ml of
1 MNaOH) such that 0.12 ml of this ‘dofetilide stock’ dissolved
in 3 l of modified Krebs–Henseleit solution yielded a 100 nM
dofetilide solution. The 50 nM dofetilide solution was prepared
from a 2 ml stock solution containing 1 ml of ‘dofetilide
stock’+1 ml of ‘vehicle stock’, such that 0.12 ml of this stock
dissolved in 3 l of modified Krebs–Henseleit solution furnished
a 50 nM dofetilide solution. The dofetilide was a generous gift
from Gedeon Richter Ltd. (Budapest, Hungary).
The 100 nM methoxamine solution was prepared from 10 ml
of ‘methoxamine stock’ consisting of 6.19 mg of methoxamine
(Sigma-Aldrich, Inc., St. Louis, MO, USA) dissolved in 10 ml
water, such that 0.12 ml of this stock dissolved in 3 l of modified
Krebs–Henseleit solution of the ‘dofetilide+methoxamine’
group and the ‘dofetilide +methoxamine+ stretch’ group
yielded a 100 nM methoxamine solution. The methoxamine
‘vehicle stock’ was 10 ml of water, and 3 l of the modified
Krebs–Henseleit solution of the ‘dofetilide+stretch’ group
contained 0.12 ml of this ‘vehicle stock’.
CaCl2 and MgSO4 were purchased from Sigma-Aldrich,
Inc., St. Louis, MO, USA. All other salts were purchased from
Molar Chemical Kft., Budapest, Hungary. Water for the
preparation of perfusion solution was obtained from a reverse
osmosis system (Milli-Q RG, Millipore Ltd., Billerca, MA,
USA) fed by distilled water, and had a specific resistivity of
>18 MΩ.
2.4. Exclusion criteria
Any heart with a sinus rate <120/min or a coronary flow
>15 ml/min/g or <3 ml/min/g 5 min before the start of the 40-
min drug perfusion protocol, or not in a constant sinus rhythm
before the start of the 40-min drug perfusion, was excluded.
2.5. Arrhythmia diagnosis and ECG analysis
Coronary flow and ECG intervals were measured at
predetermined time points. After the completion of experi-
ments, the data were replayed and the RR, PR, QRS and QT
intervals were measured by manual positioning on screen
markers. The QT interval was defined as the time between the
first deviation from the isoelectric line during the PR interval
until the end of the TU wave. Where the T or U wave
overlapped the following P wave or the QRS complex of the
subsequent sinus beat, the extrapolation method was used to
measure the length of the QT (or QU) interval (Farkas et al.,
2004). From the ECG, the incidence and the time to onset of
arrhythmias were obtained. Ventricular premature beats,
bigeminies, salvoes and ventricular fibrillation were defined
according to the Lambeth Conventions (Walker et al., 1988).
Torsade de pointes was defined as a polymorphic ventricular
tachycardia with runs of 4 or more ventricular premature beats,
where clear twisting of the QRS complexes around the
isoelectric axis could be seen in at least one ECG lead. Runs
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like twisting QRS morphology were differentiated from
torsade de pointes and were defined as ventricular tachycardia.
Blocks in the conduction system were also monitored.
Conduction disturbances included atrioventricular blocks and
intraventricular conduction defects (right or left bundle branch
block).
2.6. Statistics
Continuous data were expressed as mean±standard error of
the mean (S.E.M.). All data from independent samples, except
arrhythmia incidences, were compared with Kruskal–Wallis
tests. The incidences of arrhythmias were compared by using
Fisher's exact probability test with the Bonferoni correction, i.e.
the P values of Fisher's exact probability test were multiplied by
6 (the number of groups) to allow multiple comparisons
(Altman, 1991). P<0.05 was taken as indicative of a statis-
tically significant difference between values.
3. Results
3.1. Arrhythmia incidences
In the first set of experiments, spontaneous torsade de
pointes occurred only in the 100 nM dofetilide group (Fig. 1)
and it did so with a relatively low incidence (Table 1), which
offered scope for the examination of additional effects that can
further increase the incidence of this arrhythmia. On the other
hand, dofetilide at a concentration of 100 nM evoked
ventricular conduction blocks in a majority of the hearts
(Table 1).
In the second set of experiments, neither the sustained load-
induced left ventricular stretch nor methoxamine nor the in
combination increased the incidence of dofetilide-provokedFig. 1. Dofetilide-induced torsade de pointes ventricular tachycardia. ECG I–III, e
ventricular pressure; BG, bigeminy; TdP, torsade de pointes.torsade de pointes. However, the stretch was arrhythmogenic in
terms of increasing the incidence of salvo and of ventricular
tachycardia different from torsade de pointes as compared with
the control group, and ventricular premature beats occurred in
each heart only in those two groups in which the stretch was
applied (Table 1).
3.2. ECG intervals
Dofetilide reduced the heart rate similarly in all groups of
hearts as compared with the control (Fig. 2A). On the other
hand, dofetilide caused a concentration-dependent lengthening
of the QT interval and neither the stretch nor methoxamine
significantly affected the dofetilide-induced QT prolongation
(Fig. 2B). As there was no significant difference between the
heart rates of the dofetilide-treated groups (Fig. 2A), the QT
values were not corrected for heart rate. Dofetilide also caused a
concentration-dependent lengthening of the QRS interval (Fig.
2C).
The mean baseline PQ interval ranged from 60±1 to 74±
2 ms and remained stable throughout the experiments; there was
no significant difference between the PQ values of the various
groups at any time point of the experiments. Neither the stretch
nor methoxamine influenced the length of the PQ interval (data
not shown).
3.3. Coronary flow, left ventricular pressures
The mean coronary flow ranged from 4.0±0.6 to 7.7±
0.4 ml/min/g, and there was no significant difference between
the various groups at any time point of the experiments. Neither
the systolic nor the end-diastolic left ventricular pressure
differed significantly between the ‘dofetilide+stretch’ group
and the ‘dofetilide+methoxamine+stretch’ group. The left
ventricular systolic pressure ranged from 139±4 to 157±11mmHglectrocardiographic leads similar to standard limb leads I, II and III; LVP, left
Fig. 2. Heart rates (A), QT intervals (B) and QRS intervals (C) in isolated rabbit
hearts. In the 1st set of experiments (left), the hearts were perfused with 0 nM
dofetilide (Control) or 50 nM or 100 nM dofetilide. In the 2nd set of experiments
(right), each heart was perfused with 100 nM dofetilide, and in the 1st group
of hearts only a left ventricular stretch was added (Dof+stretch), while in the
2nd group of hearts 100 nM methoxamine was added (Dof+Methox), and in
the 3rd group of hearts 100 nM methoxamine and the stretch were added
(Dof+Methox+stretch). Drug perfusion started at “0” min. Values are mean±
S.E.M. aP<0.05 as compared with the Control group.
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diastolic pressure did not exceed 9±2 mm Hg in any of the
groups at any time point of the experiments.
4. Discussion
The present results show that neither methoxamine, which
sensitizes anaesthetized rabbits to the proarrhythmic effects of
repolarization-prolonging drugs (Carlsson et al., 1990), nor a
constant high level of left ventricular stretch, achieved by
inflation of a left ventricular balloon, nor the combination of
methoxamine and the stretch elevated the propensity of
dofetilide to induce torsade de pointes in isolated rabbit hearts.
This is in contrast with the previous speculation based on in
vivo studies that these factors play a critical role in the
development of torsade de pointes in the rabbit heart.
4.1. Sufficient dofetilide effect
It may be concluded that the lack of torsade de pointes in
the present experiments was a result of the low concentration
of dofetilide. In an earlier work on isolated guinea pig
ventricular myocytes, 100 nM dofetilide prolonged the action
potential duration and selectively inhibited the rapid compo-nent of the delayed rectifier K+ current (IKr) with an IC50
value of 31.5 nM (Jurkiewicz and Sanguinetti, 1993). In
another study (Lu et al., 2000), dofetilide lengthened the
action potential duration markedly and induced frequent early
afterdepolarizations in isolated rabbit Purkinje fibres at a
concentration of 10 nM, i.e. one-tenth of the dofetilide
concentration (100 nM) applied in the present study. In the
hearts in the present investigation, 100 nM dofetilide markedly
and significantly prolonged the QT interval and evoked
torsade de pointes, which is clear evidence of the efficient
repolarization prolongation in the rabbit (Carlsson et al.,
1990). Furthermore, 100 nM dofetilide induced conduction
blocks in most hearts and widened the QRS complex, which is
direct and indirect evidence, respectively, of extremely
prolonged repolarization and refractoriness in the conduction
system of the rabbit, which occurs when high doses of
repolarization-prolonging drugs are applied (Farkas et al.,
2004). The presence of conduction blocks in the dofetilide-
perfused hearts in this investigation suggests that the
conditions were given for functional reentry circuits to
develop as a result of a sufficient dofetilide effect. This
supports the notion that the dofetilide concentration was high
enough to set the stage for the development of torsade de
pointes in this study.
Despite the sufficient effect of 100 nM dofetilide on
repolarization and refractoriness, torsade de pointes occurred
in fewer than half of the hearts in the first set of experiments. A
zero incidence of this arrhythmia was earlier seen with 100 nM
dofetilide in isolated Langendorff-perfused rabbit hearts
(D'Alonzo et al., 1999), though that perfusion solution did
not differ significantly from the one used in the present study.
Extreme bradycardia was recently induced via a mechanical
atrioventricular block in Langendorff-perfused rabbit hearts to
achieve a higher incidence of torsade de pointes (71%) with a
lower concentration of dofetilide (30 nM) (Barrett et al., 2001).
Conversely, the induction of torsade de pointes with dofetilide
alone in most hearts was not the aim of the present study since it
would not have provided scope for the examination of
additional effects that might increase the incidence of torsade
de pointes.
4.2. Stretch did not initiate torsade de pointes
In the present experiments a constant high level of stretch did
not increase the incidence of dofetilide-induced torsade de
pointes, though the stretch was arrhythmogenic since it
increased the incidence of salvo and of ventricular tachycardia
different from torsade de pointes, and ventricular premature
beats occurred in each heart only in those two groups, in which
the stretch was applied. In theory, these stretch-induced
arrhythmias could initiate torsade de pointes in the presence
of dofetilide-produced functional reentry circuits. One possible
explanation of the lack of a stretch effect on torsade de pointes
initiation is that the absolute number of stretch arrhythmias was
still low, and the statistical possibility of a stretch-induced
arrhythmia falling in the vulnerable period of dofetilide-
produced functional reentries was therefore low. Thus, further
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might increase the incidence of dofetilide-induced torsade de
pointes. In the present experiments, the left ventricular stretch
applied was the highest that did not destroy the structure of the
ventricle and provided physiological systolic and end-diastolic
pressures. Elevation of the absolute number of stretch-induced
arrhythmias would therefore be possible only by overstretching
the left ventricle with non-physiological volumes (Eckardt et
al., 2000) or by applying a dynamically changing stretch
protocol with rapid volume pulses (Franz et al., 1992).
However, the application of such procedures was not the aim
of the study.
It is known that a stretch can shorten repolarization. In an
earlier study, a sustained load produced by a filled left
ventricular balloon shortened the duration of the monophasic
action potential in isolated Langendorff-perfused rabbit hearts
(Zabel et al., 1996). In guinea pig myocytes, a hypotonic-
induced stretch shortened the action potential duration and
counteracted the effect of the potent repolarization-prolonging
agent E4031 (Groh et al., 1996). In the present study, the QT
interval was not affected by the stretch, which implies that the
stretch did not counteract the repolarization-prolonging effect of
dofetilide.
A ventricular stretch produces complex electrophysiological
effects by inducing afterdepolarizations, increasing the disper-
sion of repolarization, slowing impulse conduction, and either
shortening or prolonging repolarization (Janse et al., 2003;
Ravens, 2003), which may affect the genesis of torsade de
pointes. However, no data have so far been published on the
contribution of a ventricular stretch to the development of
torsade de pointes. Accordingly, despite the fact that the
present study did not reveal any effect of a sustained load-
induced stretch on the occurrence of torsade de pointes in
isolated rabbit hearts perfused with dofetilide, the roles of a
ventricular stretch and stretch-induced complex electrophysi-
ological changes in the generation of torsade de pointes
necessitate further investigations in other experimental
settings.
4.3. Methoxamine did not promote torsade de pointes
In the anaesthetized rabbit model of acquired long QT
syndrome (Carlsson et al., 1990), the stimulation of α1-
adrenoceptors by either methoxamine (Carlsson et al., 1990)
or phenylephrine (Farkas et al., 1998) sensitizes the animals to
the proarrhythmic effects of repolarization-prolonging drugs.
Stimulation of the cardiac α1-adrenoceptors increases the free
intracellular Ca2+ level via an increased turnover of phospha-
tidylinositols (Fedida et al., 1993), suppresses outward K+
currents (Braun et al., 1990, 1992; Fedida et al., 1990, 1991; Li
et al., 1996) and increases the amplitude of early after-
depolarizations (Ben-David and Zipes, 1990), all of which
may contribute to the development of torsade de pointes in the
setting of prolonged repolarization.
Interestingly, methoxamine did not promote torsade de
pointes generation in rabbit hearts in the present study. In
accordance with our pilot experiments, in order to avoid adirect effect of flow reduction on arrhythmia genesis, the
maximum concentration of methoxamine was applied which
did not reduce the coronary flow. A significant coronary flow
reduction was considered undesirable for the following reason.
Myocardial anoxia or hypoxia in anaesthetized rabbits is
represented by an electrocardiographic ST segment elevation
or depression (Farkas et al., 1998). Since none of the
published in vivo rabbit proarrhythmia studies (e.g., Buchanan
et al., 1993; Carlsson et al., 1990; Farkas and Coker, 2003)
report the occurrence of an electrocardiographic ST segment
elevation or depression in the event of a significant coronary
artery constriction as a result of a high plasma concentration of
the α1-adrenoceptor agonist methoxamine or phenylephrine, it
is highly unlikely that a coronary flow reduction plays a role
in the generation of torsade de pointes in the anaesthetized
rabbit model of acquired long QT syndrome.
Unfortunately, no data are available as concerns the blood
and serum concentrations of methoxamine achieved by
continuous infusion in the in vivo rabbit model of acquired
long QT syndrome. The currently applied in vitro concentra-
tion of methoxamine (100 nM) may not match the in vivo
serum concentration of the drug achieved by continuous
venous infusion (usually at a rate of 15 μg/kg/min). However,
the minimum concentrations of methoxamine that cause
contraction of the pulmonary arteries (Haeusler, 1983), the
ear arteries (Movahedi et al., 1995) and the thoracic aorta
(Oshita et al., 1993) in the rabbit are 30 nM, 10–30 nM and
100 nM, respectively, which indicates that 100 nM methox-
amine does exert pharmacological action in the rabbit. Thus,
this concentration seems appropriate for testing the effects of
α1-adrenoceptor stimulation on torsade de pointes genesis in
vitro.
Similarly to our results, it was earlier found that metho-
xamine at a concentration of 30 nM, which is approximately
one-third of that used in the present experiments (100 nM),
did not help dofetilide (100–700 nM) to elicit torsade de
pointes consistently in isolated Langendorff-perfused rabbit
hearts (D'Alonzo et al., 1999). In that work, repolarization-
prolonging drug-induced torsade de pointes occurred frequent-
ly when acetylcholine (300 nM) was added to the methox-
amine in the perfusion solution (D'Alonzo et al., 1999). Thus,
it was concluded that the heart rate reduction achieved with
acetylcholine and the increase in intracellular Ca2+ level
caused by α1-adrenoceptor stimulation were the factors
promoting the high incidence of torsade de pointes attained
with repolarization-prolonging drugs in isolated rabbit hearts
(D'Alonzo et al., 1999). However, acetylcholine did not
reduce the heart rate significantly in that study, and there were
only a few hearts in each group perfused with a single drug or
a drug combination (D'Alonzo et al., 1999), which raises
questions concerning their conclusion of the need for
methoxamine and acetylcholine to induce torsade de pointes
in isolated rabbit hearts, since these small groups are
inappropriate for statistical comparison. Their results and
those of the present investigation rather suggest that the role of
the stimulation of intracardiac α1-adrenoceptors in the
generation of torsade de pointes in the rabbit is questionable.
124 A.S. Farkas et al. / European Journal of Pharmacology 537 (2006) 118–125Furthermore, in the setting of prolonged repolarization, the
lack of a sensitizing effect of α1-adrenoceptor stimulation in
isolated rabbit hearts and the presence of this effect in
anaesthetized rabbits implies that the extracardiac effects of
α1-adrenoceptor stimulation are the crucial factors in the
genesis of torsade de pointes.
The stimulation of extracardiac α1-adrenoceptors causes
peripheral vasoconstriction and elevates the resistance and
arterial blood pressure, which reduces the heart rate via a vagus
nerve-mediated autonomic reflex and increases the ventricular
stretch. In a recent in vivo study (Coker and Farkas, 2004),
bilateral vagotomy elevated the heart rate and prevented torsade
de pointes in anaesthetized rabbits treated with simultaneous
phenylephrine and clofilium infusions. This emphasizes the
importance of extracardiac α1-adrenoceptor stimulation-in-
duced reflex bradycardia in the anaesthetized rabbit model of
acquired long QT syndrome.
4.4. In vitro versus in vivo induction of torsade de pointes
In the present experiments, the heart rate, the QT interval
and the systolic pressure were approximately the same in the
α1-adrenoceptor-stimulated, stretched hearts perfused with
100 nM dofetilide as those recorded immediately before
torsade de pointes occurred in anaesthetized rabbits treated
with phenylephrine and D-sotalol or almokalant (published and
unpublished data of Farkas et al., 2002). Furthermore,
similarly to the results of the present study, the end-diastolic
pressure values remained virtually in the physiological range
(<10 mm Hg) in anaesthetized rabbits sensitized by
phenylephrine to the proarrhythmic effects of clofilium
(unpublished data from the study by Farkas and Coker,
2002). Thus, although isolated rabbit hearts subjected to
dofetilide, α1-adrenoceptor stimulation and stretch exhibit
nearly the same heart rate, QT interval and pressure as those
measured in α1-adrenoceptor-stimulated anaesthetized rabbits
treated with repolarization-prolonging drugs, torsade de
pointes occurs more frequently under in vivo conditions.
This strongly suggests that the generation of torsade de pointes
requires other additional factors, which are absent in the
isolated heart, but present in vivo, e.g. hormonal and/or
autonomic neuronal effects, loading of the right ventricle, a
stretch produced by an increased afterload rather than an
increased preload (which was used in the present study). The
roles of these factors in the development of torsade de pointes
demand further investigations.
5. Conclusion
The present results indicate that neither a sustained load-
induced constant high level of left ventricular stretch nor α1-
adrenoceptor stimulation nor their co-application promote the
generation of torsade de pointes in the setting of prolonged
repolarization in isolated Langendorff-perfused rabbit hearts.
The roles of intracardiac α1-adrenoceptor stimulation and a
sustained load-induced left ventricular stretch in the pro-
vocation of torsade de pointes in the rabbit are thereforequestionable. In contrast, the present results suggest the
importance of extracardiac α1-adrenoceptor stimulation in
torsade de pointes development in the rabbit heart.
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